Paclitaxel-Coated PTA Balloon Catheter
The Ranger Drug Coated balloon is indicated for Percutaneous Transluminal Angioplasty (PTA) in the peripheral vasculature. It has been designed to provide consistent and predictable drug delivery through efficient drug transfer, and a strong coating integrity.
Ranger™, for consistent and predictable drug delivery
We developed TransPax™, a proprietary coating technology designed to optimize the drug coating integrity and efficiently deliver the drug to the tissue. A loading tool and Sterling™ balloon also contribute to coating integrity, deliverability and intuitive use. With these innovations the Ranger™ DCB provides a consistent and predictable treatment option.
During the PTA procedure, the coating on drug coated balloons can be damaged prior to lesion treatment. This may result in the drug and excipient flaking off the balloon before reaching the lesion. As a consequence, the actual drug delivery to the lesion may be non-homogeneous and inconsistent.
The Next Generation of Drug-Coated Balloon: Ranger™ Paclitaxel-Coated PTA Balloon Catheter
Clinically proven in both randomised and real-world trials, the Ranger SFA-Trial has achieved among the highest freedom from TLR rate of 91% at 12 months
Proprietary TransPax coating is designed for optimal drug transfer minimizing risk for particulate loss downstream
RANGER is available on the 0.018” Sterling balloon catheter platform which contributes to its ease of use and deliverability. RANGER has a proprietary loading tool to ensure coating integrity and minimize drug loss.
A broad size matrix with BTK and SFA indications